Refractory Epilepsy: Clinical Trials

1 trial for Refractory Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1
Phase 31Withdrawn 1

Follow Refractory Epilepsy: new trials by email Literature Review of Refractory Epilepsy trials Research Report on Refractory Epilepsy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus
Traditional Treatment (Group T), Ketamine Infusion (Group K) - Refractory Epilepsy
Phase 2 / Phase 3WithdrawnUniversity of Alabama at Birmingham2017-05-042021-05-21

Narrower conditions

Drug Resistant Epilepsy (1)  ·  Seizures (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Epilepsy (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Barbiturates (1)  ·  Benzodiazepines (1)  ·  Ketamine (1)  ·  Propofol (1)  ·  Sensitivity Training Groups (1)

Sponsors

University of Alabama at Birmingham (1)

Countries

United States (1)

Top investigators

Vinodkumar Singh, MD (1)

Results publications

PMID 30232735